Matteo Lombardi

Corporate Head Of Accounting And Compliance Europe&israel at DiaSorin SpA

Matteo Lombardi currently serves as the Corporate Head of Accounting and Compliance Europe & Israel at DiaSorin, where responsibilities include preparing position papers on non-ordinary accounting matters and involvement in special projects. Prior to this role, Matteo was the Group Head of Accounting and Consolidation at SBM Offshore, overseeing teams across multiple global regions and managing group accounting, consolidation, and treasury controlling processes. Matteo's earlier experience at DiaSorin included positions such as Corporate IFRS and Consolidation Supervisor and Corporate Internal Audit Specialist, where significant contributions were made to consolidation processes, accounting policy definitions, and internal audit activities. Matteo began a career as a Senior Auditor at Deloitte & Touche, working with both Italian and international groups. Education includes a Master’s Degree in Business Administration and dual Bachelor’s Degrees in Business Law and International Business from the Università degli Studi di Torino.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


DiaSorin SpA

4 followers

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.


Industries

Headquarters

Saluggia, Italy

Employees

1,001-5,000

Links